Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

IMPACT REPORT 2017 – 2018 PATIENT STORY: MEET JUANITA GLEDHILL Juanita Gledhill had just celebrated her 50th birthday. During her annual physical, she asked her doctor for a bone density […]

Osteoporosis Canada is saddened to announce the passing of Dr. Timothy M. Murray, founding member of Osteoporosis Canada. Dr. Murray was the Emeritus Professor of Medicine at the University of […]